ArticleHealth technology assessment (Winchester, England)2026
PERsonalised Medicine for Intensification of Treatment (PERMIT) in type 2 diabetes mellitus: a target trial emulation from routine data.
David G Lugo-Palacios et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.